Drugs available for asthma treatment in the first decades of the 20th century
(sympathomimetic agents such as oral ephedrine, intravenous adrenaline, or inhaled …

Last year brought a significant advance in asthma management, unyielding to the pressure
of the pandemics. Novel key findings in asthma pathogenesis focus on the resident cell …

Background Patients with asthma who are inadequately controlled on inhaled corticosteroid–
long-acting β 2-adrenoceptor agonist (ICS–LABA) combinations might benefit from the …

Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt.
Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch …

Genomics-driven drug discovery is indispensable for accelerating the development of novel
therapeutic targets. However, the drug discovery framework based on evidence from …

Inhaled glucocorticoids (GCs) are drugs widely used as treatment for asthma patients. They
prevent the recruitment and activation of lung immune and inflammatory cells and …

The last 2 years yielded a proliferation of high-quality asthma research. These include new
understandings of the incidence and natural history of asthma, findings on the effects of …

Abstract LABA/ICS and LABA/LAMA/ICS combinations elicit beneficial effects in asthma.
Specific evidence concerning the impact of combining indacaterol acetate (IND) …

A novel, once-daily (od), fixed-dose combination (FDC) of indacaterol acetate (IND),
glycopyrronium bromide (GLY), and mometasone furoate (MF), delivered by the inhaler …

Objective: To compare exacerbation rates and healthcare resource utilization (HCRU) in
real-world patients in the United States who had moderate-to-severe asthma on medium-or …